Trials / Completed
CompletedNCT05037227
Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in Indonesia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,100 (actual)
- Sponsor
- PT Bio Farma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is evaluating safety profile of COVID-19 Vaccine in healthy adults aged \>18 years in Indonesia.
Detailed description
To assess any serious systemic reaction within 30 minutes after COVID-19 vaccine immunization. To assess systemic reaction after COVID-19 Vaccine immunization. To assess local reaction after COVID-19 Vaccine immunization. To assess any serious adverse event after COVID-19 Vaccine immunization.
Conditions
Timeline
- Start date
- 2021-09-02
- Primary completion
- 2021-10-17
- Completion
- 2021-12-27
- First posted
- 2021-09-08
- Last updated
- 2022-07-27
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05037227. Inclusion in this directory is not an endorsement.